Australian Prescriber

Subject Index: Australian Prescriber Volumes 17 to current (1994-2008)

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

To find a reference on this page either scroll or hold down the "Ctrl" key and press "f".

ulcers

foot infections in diabetes 30(1) 21-4

Ultiva

see remifentanil 21(4) 108-11

ultrasound

cerebrovascular imaging (editorial) 24(6) 134

deep venous thrombosis 30(2) 38-40; 21(3) 76-9

letter 22(2) 28-31

echocardiography 29(5) 134-8

letter 30(1) 3-4

perflutren - contrast medium - Definity (New drug) 30(4) 107-11

transcranial ultrasound 24(6) 137-40

Underneath the RADAR

moxifloxacin 26(6) 131

United Kingdom

National Health Service - prescriber feedback (editorials) 21(1) 3-4

United States

US Free Trade Agreement and pharmaceuticals (editorial) 27(3) 54-5

letter 27(5) 109-13

uric acid

management of gout 27(1) 10-3

renal calculi 19(4) 94-7

urinary calculi

management 19(4) 94-7

urinary incontinence

anticholinergic drugs 29(1) 22-4

letter 29(4) 91-3

oxybutynin - Ditropan (New drug) 17(4) 87-90

tolterodine - Detrusitol (New drug) 28(2) 49-51

urinary obstruction in prostatic hypertrophy

drug costs and benefits (editorial) 18(2) 26-7

letter 19(1) 3-6

urinary tract infections

enoxacin - Enoxin (New drug) 18(1) 7-9

management in childhood 22(2) 40-3

urination

dihydropyridines and nocturia 20(1) 3-4

Uromitexan

see mesna 20(1) 22-3; 17(1) 6-8

ursodeoxycholic acid

biliary cirrhosis - Ursofalk (New drug) 22(4) 95-8

Ursofalk (New formulation) 23(5) 110-1

Ursofalk

see ursodeoxycholic acid 22(4) 95-8

urticaria

management 24(5) 124-6

uveitis

management of ocular toxoplamosis 25(4) 88-90

Home

Useful Links

Privacy

Web Manager



	Home About Us Contact Us Index Search Consumer Topics Back Issues